SNES (SenesTech, Inc.) רווח נקי למניה (EPS TTM)

SenesTech, Inc. (SNES) develops innovative biological pest control systems, offering the harmless ContraPest agent to agricultural holdings and municipalities. Trailing twelve-month net income per share demonstrates financial stability, where the -1.35 level represents the current value. However, the slow adoption of biological methods and registration bureaucracy are hindering growth, necessitating an active expansion of distribution networks to accelerate capital inflows.

The efficiency of implementing humane rodent population control methods by SenesTech, Inc. (SNES) is reflected in the net income per share dynamics over the last four quarters. This indicator determines the portion of profit attributable to a single common share. The calculation is based on dividing the total annual net income by the total number of shares outstanding. The growth of this metric confirms the scalability of the ecological business. A steady increase in this figure signals the high investment attractiveness of the asset.